Literature DB >> 1325409

Cytomegalovirus infection, fetal liver disease, and neonatal hemochromatosis.

M M Kershisnik1, A S Knisely, C C Sun, J M Andrews, C T Wittwer.   

Abstract

Neonatal hemochromatosis is an uncommon disorder, clinicopathologically defined by severe and generally fatal liver disease of intrauterine onset associated with extrahepatic siderosis that spares reticuloendothelial elements (hemochromatotic siderosis). The agent or agents of liver disease in neonatal hemochromatosis are not known. It also is not known if intrauterine liver disease of defined infective etiology can lead to hemochromatotic siderosis. We present two patients with fetal liver disease and hemochromatotic siderosis whose cases help address these points. In the first patient rare hepatobiliary and numerous renal tubular cytomegalovirus (CMV) inclusions were found; CMV infection was confirmed by the polymerase chain reaction. Studies of the mother of the second patient 1, 5, and 9 weeks post-partum showed recent seroconversion against CMV; seroconversion against other infectious agents (toxoplasma, rubella, herpes, parvovirus B19, hepatitis A/B/C) was not present. Histologic, immunohistochemical, in situ hybridization, or polymerase chain reaction evidence of CMV infection was not present in infant tissues, even though peripartum maternal seroconversion against CMV was observed. We conclude that hemochromatotic siderosis may accompany chronic fetal liver disease of defined infective etiology (patient no. 1) and that recent maternal seroconversion against CMV in the presence of severe fetal liver disease does not necessarily mean that transplacentally acquired CMV infection caused the fetal liver disease (patient no. 2). Polymerase chain reaction documentation of infective-agent genomic sequences in fetal or infant tissues permits more accurate interpretation of maternal serologic data.

Entities:  

Mesh:

Year:  1992        PMID: 1325409     DOI: 10.1016/0046-8177(92)90272-5

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  6 in total

1.  Fetal liver iron overload: the role of MR imaging.

Authors:  Marie Cassart; Freddy Efraim Avni; Laurent Guibaud; Marc Molho; Nicky D'Haene; Alain Paupe
Journal:  Eur Radiol       Date:  2010-09-04       Impact factor: 5.315

Review 2.  Neonatal hemochromatosis.

Authors:  Amy G Feldman; Peter F Whitington
Journal:  J Clin Exp Hepatol       Date:  2013-11-27

3.  Classification and genetic features of neonatal haemochromatosis: a study of 27 affected pedigrees and molecular analysis of genes implicated in iron metabolism.

Authors:  A L Kelly; P W Lunt; F Rodrigues; P J Berry; D M Flynn; P J McKiernan; D A Kelly; G Mieli-Vergani; T M Cox
Journal:  J Med Genet       Date:  2001-09       Impact factor: 6.318

4.  Hepatic morphology and iron quantitation in perinatal hemochromatosis. Comparison with a large perinatal control population, including cases with chronic liver disease.

Authors:  M M Silver; L S Valberg; E Cutz; L D Lines; M J Phillips
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

Review 5.  Fetomaternal alloimmunity as a cause of liver disease.

Authors:  Daniel Smyk; Tassos Grammatikopoulos; Alexandros Daponte; Eirini I Rigopoulou; Dimitrios P Bogdanos
Journal:  Auto Immun Highlights       Date:  2011-03-23

6.  Primary biliary cirrhosis-specific antimitochondrial antibodies in neonatal haemochromatosis.

Authors:  Daniel S Smyk; Maria G Mytilinaiou; Tassos Grammatikopoulos; A S Knisely; Giorgina Mieli-Vergani; Dimitrios P Bogdanos; Diego Vergani
Journal:  Clin Dev Immunol       Date:  2013-09-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.